Skip to main content
. 2021 Nov 1;2021:2048833. doi: 10.1155/2021/2048833

Figure 2.

Figure 2

Patient characteristics in the high- and low-risk groups in the training set. (a) Survival distribution of high- and low-risk patients. (b) ROC curves predicting 1-, 3-, and 5-year survival rates. (c) Expression of the 8 miRNAs changed with increasing risk score. Comparisons of somatic mutation count (d) and UBQLN4 expression (e) in the high- and low-risk groups.